Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-023990
Filing Date
2022-08-24
Accepted
2022-08-24 17:15:58
Documents
49
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 669689
2 ex31-1.htm EX-31.1 17711
3 ex31-2.htm EX-31.2 17833
4 ex32-1.htm EX-32.1 6973
5 ex32-2.htm EX-32.2 6455
  Complete submission text file 0001493152-22-023990.txt   3391251

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imun-20220630.xsd EX-101.SCH 31567
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imun-20220630_cal.xml EX-101.CAL 35807
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imun-20220630_def.xml EX-101.DEF 99568
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imun-20220630_lab.xml EX-101.LAB 226784
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imun-20220630_pre.xml EX-101.PRE 178537
43 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 438594
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 221192313
SIC: 2834 Pharmaceutical Preparations